世界のペラミビル市場予測（～2028年）：溶液、固溶体

• 英文タイトル：Global Peramivir Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E8930 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

ペラミビル市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のペラミビルの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 ペラミビル市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・溶液、固溶体 用途別セグメントは次のように区分されます。 ・インフルエンザA型治療、インフルエンザB型治療 世界のペラミビル市場の主要な市場プレーヤーは以下のとおりです。 ・BioCryst Pharmaceuticals、Green Cross Pharma、Shionogi Co.、NeoPharm、Moksha8 Pharma、NT Pharma、Merck、Hikma Pharmaceuticals、Hunan Nucien Pharmaceutical Co., Ltd.、SCOLR Pharma 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、ペラミビル製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なペラミビルメーカーの企業概要、2019年～2022年までのペラミビルの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なペラミビルメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別ペラミビルの販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までのペラミビルの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのペラミビル市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、およびペラミビルの産業チェーンを掲載しています。 ・第13、14、15章では、ペラミビルの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：BioCryst Pharmaceuticals、Green Cross Pharma、Shionogi Co.、NeoPharm、Moksha8 Pharma、NT Pharma、Merck、Hikma Pharmaceuticals、Hunan Nucien Pharmaceutical Co., Ltd.、SCOLR Pharma ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：溶液、固溶体 ・用途別分析2017年-2028年：インフルエンザA型治療、インフルエンザB型治療 ・ペラミビルの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・ペラミビルのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・ペラミビルのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ペラミビルの南米市場規模2017年-2028年：ブラジル、アルゼンチン ・ペラミビルの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Peramivir market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Peramivir market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Influenza A Treatment accounting for % of the Peramivir global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Solution segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Peramivir include BioCryst Pharmaceuticals, Green Cross Pharma, Shionogi Co., NeoPharm, and Moksha8 Pharma, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Peramivir market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Solution
Solid
Market segment by Application can be divided into
Influenza A Treatment
Influenza B Treatment
The key market players for global Peramivir market are listed below:
BioCryst Pharmaceuticals
Green Cross Pharma
Shionogi Co.
NeoPharm
Moksha8 Pharma
NT Pharma
Merck
Hikma Pharmaceuticals
Hunan Nucien Pharmaceutical Co., Ltd.
SCOLR Pharma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Peramivir product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Peramivir, with price, sales, revenue and global market share of Peramivir from 2019 to 2022.
Chapter 3, the Peramivir competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Peramivir breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Peramivir market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Peramivir.
Chapter 13, 14, and 15, to describe Peramivir sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Peramivir Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Peramivir Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Solution
1.2.3 Solid
1.3 Market Analysis by Application
1.3.1 Overview: Global Peramivir Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Influenza A Treatment
1.3.3 Influenza B Treatment
1.4 Global Peramivir Market Size & Forecast
1.4.1 Global Peramivir Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Peramivir Sales in Volume (2017-2028)
1.4.3 Global Peramivir Price (2017-2028)
1.5 Global Peramivir Production Capacity Analysis
1.5.1 Global Peramivir Total Production Capacity (2017-2028)
1.5.2 Global Peramivir Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Peramivir Market Drivers
1.6.2 Peramivir Market Restraints
1.6.3 Peramivir Trends Analysis
2 Manufacturers Profiles
2.1 BioCryst Pharmaceuticals
2.1.1 BioCryst Pharmaceuticals Details
2.1.2 BioCryst Pharmaceuticals Major Business
2.1.3 BioCryst Pharmaceuticals Peramivir Product and Services
2.1.4 BioCryst Pharmaceuticals Peramivir Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Green Cross Pharma
2.2.1 Green Cross Pharma Details
2.2.2 Green Cross Pharma Major Business
2.2.3 Green Cross Pharma Peramivir Product and Services
2.2.4 Green Cross Pharma Peramivir Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Shionogi Co.
2.3.1 Shionogi Co. Details
2.3.2 Shionogi Co. Major Business
2.3.3 Shionogi Co. Peramivir Product and Services
2.3.4 Shionogi Co. Peramivir Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 NeoPharm
2.4.1 NeoPharm Details
2.4.2 NeoPharm Major Business
2.4.3 NeoPharm Peramivir Product and Services
2.4.4 NeoPharm Peramivir Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Moksha8 Pharma
2.5.1 Moksha8 Pharma Details
2.5.2 Moksha8 Pharma Major Business
2.5.3 Moksha8 Pharma Peramivir Product and Services
2.5.4 Moksha8 Pharma Peramivir Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 NT Pharma
2.6.1 NT Pharma Details
2.6.2 NT Pharma Major Business
2.6.3 NT Pharma Peramivir Product and Services
2.6.4 NT Pharma Peramivir Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business
2.7.3 Merck Peramivir Product and Services
2.7.4 Merck Peramivir Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Hikma Pharmaceuticals
2.8.1 Hikma Pharmaceuticals Details
2.8.2 Hikma Pharmaceuticals Major Business
2.8.3 Hikma Pharmaceuticals Peramivir Product and Services
2.8.4 Hikma Pharmaceuticals Peramivir Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Hunan Nucien Pharmaceutical Co., Ltd.
2.9.1 Hunan Nucien Pharmaceutical Co., Ltd. Details
2.9.2 Hunan Nucien Pharmaceutical Co., Ltd. Major Business
2.9.3 Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Product and Services
2.9.4 Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 SCOLR Pharma
2.10.1 SCOLR Pharma Details
2.10.2 SCOLR Pharma Major Business
2.10.3 SCOLR Pharma Peramivir Product and Services
2.10.4 SCOLR Pharma Peramivir Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Peramivir Breakdown Data by Manufacturer
3.1 Global Peramivir Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Peramivir Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Peramivir
3.4 Market Concentration Rate
3.4.1 Top 3 Peramivir Manufacturer Market Share in 2021
3.4.2 Top 6 Peramivir Manufacturer Market Share in 2021
3.5 Global Peramivir Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Peramivir Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Peramivir Market Size by Region
4.1.1 Global Peramivir Sales in Volume by Region (2017-2028)
4.1.2 Global Peramivir Revenue by Region (2017-2028)
4.2 North America Peramivir Revenue (2017-2028)
4.3 Europe Peramivir Revenue (2017-2028)
4.4 Asia-Pacific Peramivir Revenue (2017-2028)
4.5 South America Peramivir Revenue (2017-2028)
4.6 Middle East and Africa Peramivir Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Peramivir Sales in Volume by Type (2017-2028)
5.2 Global Peramivir Revenue by Type (2017-2028)
5.3 Global Peramivir Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Peramivir Sales in Volume by Application (2017-2028)
6.2 Global Peramivir Revenue by Application (2017-2028)
6.3 Global Peramivir Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Peramivir Sales by Type (2017-2028)
7.2 North America Peramivir Sales by Application (2017-2028)
7.3 North America Peramivir Market Size by Country
7.3.1 North America Peramivir Sales in Volume by Country (2017-2028)
7.3.2 North America Peramivir Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Peramivir Sales by Type (2017-2028)
8.2 Europe Peramivir Sales by Application (2017-2028)
8.3 Europe Peramivir Market Size by Country
8.3.1 Europe Peramivir Sales in Volume by Country (2017-2028)
8.3.2 Europe Peramivir Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Peramivir Sales by Type (2017-2028)
9.2 Asia-Pacific Peramivir Sales by Application (2017-2028)
9.3 Asia-Pacific Peramivir Market Size by Region
9.3.1 Asia-Pacific Peramivir Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Peramivir Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Peramivir Sales by Type (2017-2028)
10.2 South America Peramivir Sales by Application (2017-2028)
10.3 South America Peramivir Market Size by Country
10.3.1 South America Peramivir Sales in Volume by Country (2017-2028)
10.3.2 South America Peramivir Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Peramivir Sales by Type (2017-2028)
11.2 Middle East & Africa Peramivir Sales by Application (2017-2028)
11.3 Middle East & Africa Peramivir Market Size by Country
11.3.1 Middle East & Africa Peramivir Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Peramivir Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Peramivir and Key Manufacturers
12.2 Manufacturing Costs Percentage of Peramivir
12.3 Peramivir Production Process
12.4 Peramivir Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Peramivir Typical Distributors
13.3 Peramivir Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---